Prosecution Insights
Last updated: April 19, 2026

Baker Botts, LLP

27 pending office actions • 11 clients

Portfolio Summary

27
Total Pending OAs
6
Final Rejections
21
Non-Final OAs

Client Portfolio (11 clients)

Client (Assignee)Pending OAs
Genentech, Inc. 7
Genentech, Inc. 4
Spark Therapeutics, Inc. 4
Brother Kogyo Kabushiki Kaisha 3
Broadstone Technologies, LLC 2
Spark Therapeutics, Inc. 2
Sol-Gel Technologies Ltd. 1
Virtualz Computing Corporation 1
The Regents of the University of Colorado 1
Sanden Corporation 1
Iridium Satellite LLC 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19326617 Untitled Genentech, Inc. NATARAJAN, MEERA 1643 Non-Final OA
19409123 Untitled Genentech, Inc. TAYLOR, LIA ELAN 1641 Non-Final OA
19266342 TREATMENT AND PREVENTION OF BASAL CELL CARCINOMA WITH TOPICAL COMPOSITION COMPRISING PATIDEGIB Sol-Gel Technologies Ltd. MCKOY, QUINCY ANDRE 1626 Non-Final OA Jul 11, 2025
19088345 SYSTEM AND METHOD FOR SELECTIVE MIGRATION OF MAINFRAME RESOURCES TO A NON-MAINFRAME ENVIRONMENT Virtualz Computing Corporation MCQUITERY, DIEDRA M 2166 Non-Final OA Mar 24, 2025
18948141 SYSTEM AND METHOD FOR TELEMETRY ANALYSIS OF A DIGITAL TWIN Broadstone Technologies, LLC NGUYEN, ANH 2458 Non-Final OA Nov 14, 2024
18752501 MULTI-VECTOR RECOMBINASE MEDIATED CASSETTE EXCHANGE Genentech, Inc. KONOPKA, CATHERINE ANNE 1635 Final Rejection Jun 24, 2024
18737142 RECORDING SYSTEM, DATA GENERATING METHOD, AND MEDIUM Brother Kogyo Kabushiki Kaisha ROGERS, SCOTT A 2683 Non-Final OA Jun 07, 2024
18631414 METHODS FOR PREDICTING RISK OF INTERSTITIAL PNEUMONIA The Regents of the University of Colorado SITTON, JEHANNE SOUAYA 1682 Non-Final OA Apr 10, 2024
18568530 AAV VECTOR COLUMN PURIFICATION METHODS Spark Therapeutics, Inc. WANG, RUIXUE 1672 Non-Final OA Dec 08, 2023
18514280 MODIFIED CELLS FOR THE PRODUCTION OF A RECOMBINANT PRODUCT OF INTEREST Genentech, Inc. MCKNIGHT, CIARA A 1656 Non-Final OA Nov 20, 2023
18494465 IMAGE FORMING APPARATUS, COMPUTER-READABLE STORAGE MEDIUM, AND METHOD FOR SELECTING BORDERED PRINTING OR BORDERLESS PRINTING Brother Kogyo Kabushiki Kaisha RICHMOND, SCOTT A. 2853 Non-Final OA Oct 25, 2023
18494452 LIGHT SOURCE DEVICE HAVING POSITIONING PART ON HOLDER FOR POSITIONING OF COUPLING LENS RELATIVE THERETO, AND SCANNING OPTICAL DEVICE USING THE SAME Brother Kogyo Kabushiki Kaisha STANFORD, CHRISTOPHER J 2872 Non-Final OA Oct 25, 2023
18281264 AIR CONDITIONING APPARATUS HAVING AN INVERTER BETWEEN AN AXIAL FAN AND AN EVAPORATOR Sanden Corporation BRADFORD, JONATHAN 3763 Final Rejection Sep 08, 2023
18124096 PURIFICATION OF MULTISPECIFIC ANTIBODIES Genentech, Inc. BRISTOL, LYNN ANNE 1643 Non-Final OA Mar 21, 2023
18173002 ASSAYS AND REAGENTS FOR CHARACTERIZATION OF MHCI PEPTIDE BINDING Genentech, Inc. LUSI, ELLIS FOLLETT 1677 Non-Final OA Feb 22, 2023
18153259 CELL-BASED METHODS FOR PREDICTING POLYPEPTIDE IMMUNOGENICITY Genentech, Inc. IVICH, FERNANDO NMN 1678 Non-Final OA Jan 11, 2023
18052486 SYSTEMS AND METHODS FOR TYROSINASE-MEDIATED SITE-SPECIFIC PROTEIN CONJUGATION Genentech, Inc. MOORE, SUSANNA 1624 Non-Final OA Nov 03, 2022
17957458 IDENTIFYING WIRELESS COMMUNICATIONS CONNECTION OPTIONS Iridium Satellite LLC LE, LANA N 2648 Non-Final OA Sep 30, 2022
17932885 SYSTEMS AND METHODS TO TRACK THE EVOLUTION OF SINGLE CELLS Genentech, Inc. BOESEN, CHRISTIAN C 1684 Non-Final OA Sep 16, 2022
17671526 System and Method for Identifying and Predicting Risk Broadstone Technologies, LLC LESNIEWSKI, VICTOR D 2493 Non-Final OA Feb 14, 2022
17052097 PLASMID FREE AAV VECTOR PRODUCING CELL LINES Spark Therapeutics, Inc. SALVOZA, M FRANCO G 1672 Non-Final OA Oct 30, 2020
16627227 AAV VECTOR COLUMN PURIFICATION METHODS Spark Therapeutics, Inc. TSAY, MARSHA M 1656 Non-Final OA Dec 27, 2019
16653167 METHODS OF TREATING RESIDUAL BREAST CANCER WITH TRASTUZUMAB EMTANSINE Genentech, Inc. SKOKO III, JOHN JOSEPH 1643 Non-Final OA Oct 15, 2019
16319216 SCALABLE HIGH RECOVERY METHODS FOR PRODUCING HIGH YIELD RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTOR AND RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTORS PRODUCED THEREBY Spark Therapeutics, Inc. JADHAO, SAMADHAN JAISING 1672 Final Rejection Jan 18, 2019
16185369 METHODS OF DECREASING TRISULFIDE BONDS DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES Genentech, Inc. BELYAVSKYI, MICHAIL A 1644 Final Rejection Nov 09, 2018
16088693 CELL LINE FOR RECOMBINANT PROTEIN AND/OR VIRAL VECTOR PRODUCTION Spark Therapeutics, Inc. NICOL, ALEXANDER W 1634 Final Rejection Sep 26, 2018
15780542 SCALABLE METHODS FOR PRODUCING RECOMBINANT ADENO-ASSOCIATED VIRAL (AAV) VECTOR IN SERUM-FREE SUSPENSION CELL CULTURE SYSTEM SUITABLE FOR CLINICAL USE Spark Therapeutics, Inc. GRABER, JAMES J 1631 Final Rejection May 31, 2018

Managing Baker Botts, LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month